These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 29266218)

  • 1. Opportunity cost of annual screening mammography.
    Keen JD
    Cancer; 2018 Mar; 124(6):1297-1298. PubMed ID: 29266218
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply to Opportunity cost of annual screening mammography.
    Arleo EK; Hendrick RE; Helvie MA; Sickles EA
    Cancer; 2018 Mar; 124(6):1298-1299. PubMed ID: 29266244
    [No Abstract]   [Full Text] [Related]  

  • 3. Annual Combined Mammography and Tomosynthesis Screening: Is It Really Cost-Effective?
    Lee CI; Lee JM; Tosteson AN
    AJR Am J Roentgenol; 2016 Nov; 207(5):1156-1158. PubMed ID: 27533738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Demonstration of Classic Screening Biases, Not Additional Benefit of Annual Over Biennial Screening.
    Barratt A; Bell K; Jacklyn G
    J Am Coll Radiol; 2018 Oct; 15(10):1360. PubMed ID: 30286894
    [No Abstract]   [Full Text] [Related]  

  • 5. Cost-effectiveness of digital mammography screening before the age of 50 in The Netherlands.
    Sankatsing VD; Heijnsdijk EA; van Luijt PA; van Ravesteyn NT; Fracheboud J; de Koning HJ
    Int J Cancer; 2015 Oct; 137(8):1990-9. PubMed ID: 25895135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accurate Inputs for Costs and Benefits of Screening Mammography.
    Baker JA
    AJR Am J Roentgenol; 2018 Jul; 211(1):W80. PubMed ID: 29932767
    [No Abstract]   [Full Text] [Related]  

  • 7. Cost-effectiveness of annual versus biennial screening mammography for women with high mammographic breast density.
    Pataky R; Ismail Z; Coldman AJ; Elwood M; Gelmon K; Hedden L; Hislop G; Kan L; McCoy B; Olivotto IA; Peacock S
    J Med Screen; 2014 Dec; 21(4):180-8. PubMed ID: 25186116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mammography screening for breast cancer.
    Wiwanitkit V
    Maturitas; 2010 Aug; 66(4):435. PubMed ID: 20541879
    [No Abstract]   [Full Text] [Related]  

  • 9. Value Analysis of Digital Breast Tomosynthesis for Breast Cancer Screening in a US Medicaid Population.
    Miller JD; Bonafede MM; Herschorn SD; Pohlman SK; Troeger KA; Fajardo LL
    J Am Coll Radiol; 2017 Apr; 14(4):467-474.e5. PubMed ID: 28139412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Women aged 75 years and older benefit from mammography.
    Printz C
    Cancer; 2015 Jan; 121(2):165. PubMed ID: 25581117
    [No Abstract]   [Full Text] [Related]  

  • 11. Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging.
    Saadatmand S; Tilanus-Linthorst MM; Rutgers EJ; Hoogerbrugge N; Oosterwijk JC; Tollenaar RA; Hooning M; Loo CE; Obdeijn IM; Heijnsdijk EA; de Koning HJ
    J Natl Cancer Inst; 2013 Sep; 105(17):1314-21. PubMed ID: 23940285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of assumptions - the example of the Welch-analysis of mammography screening effectiveness.
    Lynge E; Beau AB; Lophaven S
    Acta Oncol; 2017 Aug; 56(8):1131-1133. PubMed ID: 28488450
    [No Abstract]   [Full Text] [Related]  

  • 13. Cost-effectiveness of opportunistic versus organised mammography screening in Switzerland.
    de Gelder R; Bulliard JL; de Wolf C; Fracheboud J; Draisma G; Schopper D; de Koning HJ
    Eur J Cancer; 2009 Jan; 45(1):127-38. PubMed ID: 19038540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Total cost-effectiveness of mammography screening strategies.
    Mittmann N; Stout NK; Lee P; Tosteson AN; Trentham-Dietz A; Alagoz O; Yaffe MJ
    Health Rep; 2015 Dec; 26(12):16-25. PubMed ID: 26676235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overestimation of the Benefit-to-Harm Ratio of Risk-Based Mammography Screening in the United Kingdom.
    Autier P
    JAMA Oncol; 2019 Mar; 5(3):428. PubMed ID: 30653221
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of screening mammography in the era of modern breast cancer treatment.
    Miller AB
    Climacteric; 2018 Jun; 21(3):204-208. PubMed ID: 29338480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insights Into Breast Cancer Screening: A Computer Simulation of Two Contemporary Screening Strategies.
    Carter KJ; Castro F; Morcos RN
    AJR Am J Roentgenol; 2018 Mar; 210(3):564-571. PubMed ID: 29323554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted breast screening could reduce overdiagnosis and be more cost effective, study finds.
    Thornton J
    BMJ; 2018 Jul; 362():k3009. PubMed ID: 29980526
    [No Abstract]   [Full Text] [Related]  

  • 19. Cost-effectiveness analysis of mammography screening in Hong Kong Chinese using state-transition Markov modelling.
    Wong IO; Kuntz KM; Cowling BJ; Lam CL; Leung GM
    Hong Kong Med J; 2010 Jun; 16 Suppl 3():38-41. PubMed ID: 20601733
    [No Abstract]   [Full Text] [Related]  

  • 20. Age to Begin and Intervals for Breast Cancer Screening: Balancing Benefits and Harms.
    Destounis S; Santacroce A
    AJR Am J Roentgenol; 2018 Feb; 210(2):279-284. PubMed ID: 29064754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.